|
|
|
Print this article 
Roger McClellan Receives Special Recognition for Endowment Fund Success
SOT President Kenneth S. Ramos presented Endowment Fund Board Chair Roger O. McClellan with a special tribute during the SOT Business Meeting on March 17 at the SOT 2009 Annual Meeting.
Dr. McClellan received a lovely and unique floral arrangement with each of the flowers tagged with the name of one of the Endowment Funds. All of these funds (4 General Purpose and now 24 Specific Purpose Funds) have been established to advance the science of toxicology by providing an extra measure of financial support for SOT programs.
 |
Dr. McClellan noted in his remarks to the SOT Annual Business Meeting attendees that support for the Endowment Fund has grown each year, resulting in a total of $415,948 in contributions at the time of the Annual Meeting, matched with $415,948 provided by the SOT 50th Anniversary Match. With the continued commitment of donors, the million dollar mark is well in reach. More than 300 individuals/families and 15 corporations have contributed to the fund. There are multiple options for gifting, including:
- Cash Equivalent (Check, Credit Card)
- Transfer from Charitable or IRA Account
- Appreciated Securities
- Charitable Gift Annuities naming SOT as beneficiary
- Bequests naming SOT as beneficiary
In order to be recognized in the next SOT Endowment Annual Report, contributions must be received by the end of the fiscal year, June 30. You are encouraged to visit the SOT Web site and use the Endowment Donor Form.
The newest fund, the Dharm V. Singh Carcinogenesis Awards Fund, was established in April 2009, shortly after the Annual Meeting. This Fund was created with an initial generous contribution from Dr. Singh in memory of his wife, Sita Singh, and is intended to foster research that will lead to a better understanding of the causes of cancer and improve the diagnosis and treatment of cancer. The proceeds from the fund are to be used to encourage students and postdoctoral fellows within the first 3 years of training to conduct research in this field. The initial contribution and associated matching funds resulted in the Dharm V. Singh Carcinogenesis Awards Fund having assets of $25,000, thereby qualifying it as a "Permanently Restricted Net Asset Fund" that will be continued in perpetuity. This fund will be aligned with the Carcinogenesis Specialty Section, which will have the responsibility for identifying the number of awards to be given each year, the detailed criteria for selection of the award recipients, the selection of recipients, and the bestowing of the awards at an event held in conjunction with the SOT Annual Meeting.
Many of the 2009 graduate student and postdoctoral fellow Endowment award recipients will be recognized in the 2008–2009 Endowment Fund Annual Report. It is clear from their statements that the Endowment Funds are instrumental in building the future of toxicology, one of the top priorities of the SOT Strategic Plan. For more information about the funds, please visit the SOT Endowment Fund section of the Web site.
|
